Hau Pham, MD
Assistant Professor
Boston University School of Medicine
Dept of Surgery
Podiatry Surgery

DPM, Pennsylvania College of Podiatric Medicine



Expertise includes: Diabetic Foot Ulcers; Charcot Neuroarthropathy; Wound care; Wound healing.


A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects with Chronic Wounds in the Lower Extremities
02/17/2014 - 02/16/2017 (PI)
LifeNet Health


A Prospective, Randomized, Controlled Clinical Trial evaluating Health Economics, Safety and Efficacy of ConvaTec Engenex Negative PRessure Wound Therapy (NPWT) to KCI VAC NPWT in Treatment of Po
06/01/2011 - 12/31/2015 (PI)
ConvaTec


A Randomized, Double-Blind, Parallel-Group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-Healing Foot Ulcers in Subjects with Diabetes Mellit
08/08/2013 - 11/14/2015 (PI)
Derma Sciences, Inc.



A Feasibility Study of APT001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
05/01/2017 - 05/01/2020 (PI)
Origin, Inc

A U.S. Piggy-backed Health Economic Study of the Cost and Resource Utilization of a Topical Gentami…
02/09/2016 - 01/31/2018 (PI)
Innocoll Pharmaceuticals

A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of…
11/19/2015 - 11/19/2017 (PI)
Innocoll Pharmaceuticals



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Cazzell S, Vayser D, Pham H, Walters J, Reyzelman A, Samsell B, Dorsch K, Moore M. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair Regen. 2017 May; 25(3):483-497. PMID: 28544150.
  2. Walters J, Cazzell S, Pham H, Vayser D, Reyzelman A. Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers. Eplasty. 2016; 16:e10. PMID: 26933467; PMCID: PMC4750365.
  3. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002 Jul; 137(7):822-7. PMID: 12093340.
  4. Caselli A, Pham H, Giurini JM, Armstrong DG, Veves A. The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care. 2002 Jun; 25(6):1066-71. PMID: 12032116.
  5. Pham HT, Exelbert L, Segal-Owens AC, Veves A. A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ostomy Wound Manage. 2002 May; 48(5):30-6. PMID: 12046488.
  6. Pham HT, Rich J, Veves A. Using living skin equivalents for diabetic foot ulceration. Int J Low Extrem Wounds. 2002 Mar; 1(1):27-32. PMID: 15871949.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 6 publications over 3 distinct years, with a maximum of 4 publications in 2002

YearPublications
20024
20161
20171
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Diabetes
Foot
Ulcers
Wound

Available to Mentor as: (Review Mentor Role Definitions):
  • Research / Scholarly Mentor
Contact for Mentoring:


732 Harrison Ave
Boston MA 02118
Google Map


Pham's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department